The Potential of Cancer Biomarkers : From Discovery to Clinical Application. Este artículo no está disponible.
Idioma: inglés
Editorial: Elsevier Science Jun 2025, 2025
- Tapa dura
- Nuevo

Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Vendedor de IberLibro desde 14 de agosto de 2006
Condición: Nuevo
EUR 225,00
Descripción del artículo del vendedor
Neuware - The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.…
N° de ref. del artículo 9780443292798
- Título
- The Potential of Cancer Biomarkers : From Discovery to Clinical Application
- Autor
- Pranav Kumar Prabhakar
- Editorial
- Elsevier Science Jun 2025
- Año de publicación
- 2025
- Estado
- Neu
- Encuadernación
- Buch
- Idioma
- inglés
- ISBN 10
- 0443292795
- ISBN 13
- 9780443292798
- Peso del artículo
- 975 gramos
- Dimensiones
- 239x200x25 mm
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.
“Acerca de” puede pertenecer a otra edición de este título.